Published in J Am Chem Soc on January 14, 2014
Stimuli-responsive nanomaterials for biomedical applications. J Am Chem Soc (2015) 0.97
Dye Encapsulation in Polynorbornene Micelles. Langmuir (2015) 0.75
Picoliter Drop-On-Demand Dispensing for Multiplex Liquid Cell Transmission Electron Microscopy. Microsc Microanal (2016) 0.75
Imaging the polymerization of multivalent nanoparticles in solution. Nat Commun (2017) 0.75
Cryo-electron microscopy of viruses. Nature (1984) 6.80
Observation of single colloidal platinum nanocrystal growth trajectories. Science (2009) 2.89
High-resolution EM of colloidal nanocrystal growth using graphene liquid cells. Science (2012) 2.28
Dynamic microscopy of nanoscale cluster growth at the solid-liquid interface. Nat Mater (2003) 2.07
Direction-specific interactions control crystal growth by oriented attachment. Science (2012) 1.47
Metal-directed, chemically tunable assembly of one-, two- and three-dimensional crystalline protein arrays. Nat Chem (2012) 1.45
Structure of wet specimens in electron microscopy. Improved environmental chambers make it possible to examine wet specimens easily. Science (1974) 1.38
Controlled growth of nanoparticles from solution with in situ liquid transmission electron microscopy. Nano Lett (2011) 1.36
Real-time imaging of Pt3Fe nanorod growth in solution. Science (2012) 1.31
Control of radiation damage in the TEM. Ultramicroscopy (2012) 1.24
Nanocrystal diffusion in a liquid thin film observed by in situ transmission electron microscopy. Nano Lett (2009) 1.23
Nanoscale imaging of whole cells using a liquid enclosure and a scanning transmission electron microscope. PLoS One (2009) 1.11
Controlling and switching the morphology of micellar nanoparticles with enzymes. J Am Chem Soc (2011) 1.11
Direct in situ determination of the mechanisms controlling nanoparticle nucleation and growth. ACS Nano (2012) 1.11
Programmable shape-shifting micelles. Angew Chem Int Ed Engl (2010) 1.10
Stimuli-responsive copolymer solution and surface assemblies for biomedical applications. Chem Soc Rev (2013) 1.06
Efficient synthesis of narrowly dispersed brush copolymers and study of their assemblies: the importance of side chain arrangement. J Am Chem Soc (2009) 1.01
In situ transmission electron microscopy of lead dendrites and lead ions in aqueous solution. ACS Nano (2012) 1.00
Charged nanoparticle dynamics in water induced by scanning transmission electron microscopy. Langmuir (2012) 0.98
A new design for light-breakable polymer micelles. J Am Chem Soc (2005) 0.98
Atomic-scale imaging and spectroscopy for in situ liquid scanning transmission electron microscopy. Microsc Microanal (2012) 0.97
Visualizing macromolecular complexes with in situ liquid scanning transmission electron microscopy. Micron (2012) 0.95
Direct demonstration of the cross-bridge recovery stroke in muscle thick filaments in aqueous solution by using the hydration chamber. Proc Natl Acad Sci U S A (2008) 0.93
Low-dose aberration corrected cryo-electron microscopy of organic specimens. Ultramicroscopy (2008) 0.93
3D motion of DNA-Au nanoconjugates in graphene liquid cell electron microscopy. Nano Lett (2013) 0.88
Nanosecond time-resolved investigations using the in situ of dynamic transmission electron microscope (DTEM). Ultramicroscopy (2008) 0.86
Liquid cell transmission electron microscopy study of platinum iron nanocrystal growth and shape evolution. J Am Chem Soc (2013) 0.86
In-situ transmission electron microscopy of liposomes in an aqueous environment. Langmuir (2013) 0.79
Spontaneous assembly of miktoarm stars into vesicular interpolyelectrolyte complexes. Macromol Rapid Commun (2013) 0.77
Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90
Different cyclic motifs in phosphoric triamides containing a C(O)NHP(O)(NH)2 skeleton and an R(2)(2)(10) graph set in three new compounds: a database analysis of hydrogen-bond strengths based on motifs. Acta Crystallogr C (2011) 5.45
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem (2004) 3.57
Gold(III) and platinum(II) polypyridyl double salts and a general metathesis route to metallophilic interactions. Inorg Chem (2006) 2.14
Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res (2002) 1.98
Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons. J Neurosci (2004) 1.91
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther (2005) 1.89
Comet 81P/Wild 2 under a microscope. Science (2006) 1.83
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res (2003) 1.79
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Mol Pharmacol (2006) 1.75
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol Pharmacol (2002) 1.62
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol (2005) 1.61
Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano (2011) 1.61
Formation of the spinel phase in the layered composite cathode used in Li-ion batteries. ACS Nano (2012) 1.60
N,N'-Di-tert-butyl-N''-(2,6-difluoro-benzo-yl)phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online (2010) 1.59
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come! J Clin Oncol (2002) 1.56
N,N'-Dibenzyl-N''-(2,6-difluoro-benzo-yl)-N,N'-dimethyl-phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online (2010) 1.56
The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Mol Pharmacol (2008) 1.56
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol (2004) 1.53
The internalization and degradation of human copper transporter 1 following cisplatin exposure. Cancer Res (2006) 1.51
FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci (2009) 1.51
Structure of adeno-associated virus serotype 5. J Virol (2004) 1.50
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res (2004) 1.49
Comparison of comet 81P/Wild 2 dust with interplanetary dust from comets. Science (2008) 1.48
Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol (2006) 1.48
Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci (2002) 1.48
Imaging of transient structures using nanosecond in situ TEM. Science (2008) 1.47
Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol (2009) 1.44
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin Cancer Res (2004) 1.44
(R)-N-Methyl-4-[2-(methyl-sulfan-yl)pyrimidin-4-yl]-1-(tetra-hydro-furan-3-yl)-1H-pyrazol-5-amine. Acta Crystallogr Sect E Struct Rep Online (2009) 1.42
How risk management can prevent future wildfire disasters in the wildland-urban interface. Proc Natl Acad Sci U S A (2013) 1.41
Methyl 3-[3-(ethoxy-carbon-yl)thio-ureido]-1H-pyrazole-5-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.41
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol Pharmacol (2004) 1.41
μ-Oxalato-bis-[bis-(triphenyl-phosphine)copper(I)] dichloro-methane disolvate. Acta Crystallogr Sect E Struct Rep Online (2013) 1.38
Variable character of O-O and M-O bonding in side-on (eta(2)) 1:1 metal complexes of O2. Proc Natl Acad Sci U S A (2003) 1.38
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. Clin Cancer Res (2009) 1.37
Controlled growth of nanoparticles from solution with in situ liquid transmission electron microscopy. Nano Lett (2011) 1.36
Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci (2008) 1.35
Oocyte CD9 is enriched on the microvillar membrane and required for normal microvillar shape and distribution. Dev Biol (2006) 1.33
Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol (2006) 1.33
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem (2007) 1.30
Transport of cisplatin by the copper efflux transporter ATP7B. Mol Pharmacol (2007) 1.30
Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells. Clin Cancer Res (2005) 1.30
Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol (2002) 1.30
Retention or inversion in stereospecific nickel-catalyzed cross-coupling of benzylic carbamates with arylboronic esters: control of absolute stereochemistry with an achiral catalyst. J Am Chem Soc (2013) 1.26
Synthesis and reactions of molybdenum triamidoamine complexes containing hexaisopropylterphenyl substituents. Inorg Chem (2003) 1.25
Substrate oxidation by copper-dioxygen adducts: mechanistic considerations. J Am Chem Soc (2005) 1.24
DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res (2004) 1.24
Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase. J Neurosci (2005) 1.23
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells. Clin Cancer Res (2004) 1.23
Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc Natl Acad Sci U S A (2011) 1.23
Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Clin Cancer Res (2009) 1.22
Targeted guanine oxidation by a dinuclear copper(II) complex at single stranded/double stranded DNA junctions. Inorg Chem (2006) 1.22
A chromium catalyst for the polymerization of ethylene as a homogeneous model for the phillips catalyst. J Am Chem Soc (2005) 1.22
Pd-catalyzed enantioselective C-H iodination: asymmetric synthesis of chiral diarylmethylamines. J Am Chem Soc (2013) 1.20
Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin. Mol Pharmacol (2003) 1.20
Characterization of the chloranilate(*3-) pi radical as a strong spin-coupling bridging ligand. Inorg Chem (2006) 1.19
A linear, O-coordinated eta1-CO2 bound to uranium. Science (2004) 1.18
Structural insight into the unique properties of adeno-associated virus serotype 9. J Virol (2012) 1.18
Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Nat Protoc (2009) 1.16
Contrasting copper-dioxygen chemistry arising from alike tridentate alkyltriamine copper(I) complexes. J Am Chem Soc (2002) 1.16
Synthesis, characterization, and physicochemical properties of manganese(III) and manganese(V)-oxo corrolazines. Inorg Chem (2005) 1.16
Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. J Inorg Biochem (2008) 1.16
Cycling of the signaling protein phospholipase D through cilia requires the BBSome only for the export phase. J Cell Biol (2013) 1.16
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors. Clin Cancer Res (2004) 1.14
Mus81-Mms4 functions as a single heterodimer to cleave nicked intermediates in recombinational DNA repair. Mol Cell Biol (2012) 1.13
Expression of the human copper influx transporter 1 in normal and malignant human tissues. J Histochem Cytochem (2006) 1.12
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
Controlling and switching the morphology of micellar nanoparticles with enzymes. J Am Chem Soc (2011) 1.11
Direct in situ determination of the mechanisms controlling nanoparticle nucleation and growth. ACS Nano (2012) 1.11
Red and yellow solvates of chloro(2,2':6',2''-terpyridine)platinum(II) chloride and Pt...Pt interactions. Acta Crystallogr C (2006) 1.11
Active-site models for iron hydrogenases: reduction chemistry of dinuclear iron complexes. Inorg Chem (2006) 1.11
Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system. Clin Cancer Res (2006) 1.10
High-resolution low-dose scanning transmission electron microscopy. J Electron Microsc (Tokyo) (2009) 1.10
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol (2003) 1.10
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Trans (2011) 1.10
A supramolecular approach to an allosteric catalyst. J Am Chem Soc (2003) 1.10
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol (2002) 1.10
Intra-arterial chemotherapy for head and neck cancer: is there a verdict? Cancer (2010) 1.10
Programmable shape-shifting micelles. Angew Chem Int Ed Engl (2010) 1.10
In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. Vaccine (2008) 1.09
Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia (2012) 1.09
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance. Mol Cancer Ther (2006) 1.09
Asymmetry of the "strongest" OHO hydrogen bond, in the monoanion of (+/-)-alpha,alpha'-di-tert-butylsuccinate. J Am Chem Soc (2009) 1.08
Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling. Proc Natl Acad Sci U S A (2014) 1.08
Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response. PLoS One (2009) 1.08
N-(2-Fluoro-benzo-yl)-N',N''-bis-(4-methyl-phen-yl)phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online (2011) 1.08
Metal-dependent reactions of bulky metal(II) amides M[N(SiMe3)2]2 with 3,3'-disubstituted binaphthols (HO)2C20H10(SiR3)2-3,3': selective conversion of one equivalent -OH group to a silyl ether -OSiMe3. Inorg Chem (2008) 1.07
Highly diastereoselective synthesis of tetrahydropyridines by a C-H activation-cyclization-reduction cascade. J Am Chem Soc (2012) 1.07
Structural studies of bacteriophage alpha3 assembly. J Mol Biol (2003) 1.06
Substituent control of hydrogen bonding in palladium(II)-pyrazole complexes. Inorg Chem (2003) 1.06
CF3 rotation in 3-(trifluoromethyl)phenanthrene. X-ray diffraction and ab initio electronic structure calculations. J Phys Chem A (2006) 1.06
Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol Pharmacol (2010) 1.06